THE TAPE

Grifois, S.A.

$8.73▲ +0.46%
Last close
Relative strength
59RS
of 99, against every stock▲ +32 on the month
Powering up
Turning
−0.1%
six months against Pharmaceutical Preparations
52-week range
−10.6%
from the high
$6.96$9.77
Setup
On no screen
No base, flag or squeeze in place tonight. What is and is not there
No report date on the calendar.
No US GAAP filings to read.
Why it is on no screen

GRFS is off the screens on one check: relative strength.

A base has formed10.4 weeks, from 7.15 to 8.38.
Long enough to count10.4 weeks against 3 needed.
Shallow enough14.7% deep against 35% allowed.
Close to its pivot+4.2% from the pivot; listed down to -20%.
Relative strengthRS 59 against 70 needed.

Measured against the base-and-breakout thresholds. The other screens use their own numbers, so a name can miss here and still be a fair-looking chart.

Draw
9-dayabout two weeks21-dayabout a month50-dayabout a quarter200-dayabout a year
Support and resistance
Support below
$8.33
-4.6% · tested 4× · last 6 sessions ago
Resistance above
None within the last 120 sessions

Prices this stock has turned at three or more times in the last 120 sessions, with how many times. Where buyers and sellers showed up before, not a forecast, an entry or a stop.

The read

Grifois, S.A. is not on any of the screens right now. Its relative strength rating is 59, and it sits in Pharmaceutical Preparations.

Against its industry
TurningBehind its industry over six months, but ahead over one and three.
One month against its industry
+9.4%
Three months against its industry
+30.1%
Six months against its industry
-0.1%

Read against an equal-weighted index of Pharmaceutical Preparations, which is +10.9% against the S&P 500 over six months Partly aligned.

Peers
Catalyst roadmap
17
days
Ex-dividend in 17 days
Dec 3, 2026
  1. Ex-dividendconfirmedin 17d
    Ex-dividend date
    Dec 3, 2026
How it moves on earnings

On average 4.8% either way across its last 2 reports.

Checking your subscription…

Close before the report day to close after it, so it holds whether the company reported before the open or after the close.

The business

No figures in US GAAP filings for this company. Most foreign listings report under international standards, which this does not read.

Tracked funds

None of the tracked funds held or sold it in their latest filings.

Flagged by the market sweep

Nothing flagged for this company on the last market sweep.

In the news

No headlines for this company in the last couple of weeks.

Insiders

No Form 4 filings read for this company in the last six months. That can mean nobody filed, or that this name has not been on a screen long enough for us to have fetched them.

What analysts expect
Strong buy0
Buy1
Hold1
Sell0
Strong sell0

These are analysts’ estimates, not ours, and not a projection this site endorses. They are published here because what the sell side expects is itself a fact about the market.

Checking your subscription…

Gamma concentration

No option open interest for this company. Most listed names have no options at all, and we only read chains for names carrying a dated event, so this is a normal reading rather than a fault.

X-ray

No completed base to compare this one with yet.

A screening and market-analytics tool. Not investment advice. We are not a registered investment adviser. A stock on a screen matches a shape; that is not a prediction. Prices are end-of-day, not live.

What that means, in full
Grifois, S.A. (GRFS) — The Tape